Toxicologists offer their perspectives on the future of testing.
News & Features
Scientists in Australia have developed an ingestible sensor to detect and measure gut gasses in the stomach. The data can be sent to a phone or computer and could change the way gut disorders are diagnosed and treated.
General Electric is considering breakup options after taking a major tax hit related to an old portfolio of long-term care insurance.
FDA said it will delay implementing a rule put forth last year that would have changed how it determines the intended use of a medical product.
Lombard Medical Technologies has defaulted on a loan and said it doesn't have enough cash to survive past the first half of this year. Here's a look at how things went from bad to worse for Lombard.
AI, VR, and concept cars grabbed most of the headlines at this year's CES consumer electronics show in Las Vegas, but these medical technologies on display at the event could help make a real difference in people's lives.
Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
Medtronic was one of four multinational companies chastised by Chinese regulators for referring to Taiwan as a country online.
The recently lowered U.S. corporate tax rate was a hot topic in San Francisco, CA where thousands of industry executives and investors convened for the 36th annual J.P. Morgan Healthcare Conference. We combed through dozens of company slideshows and tuned into live webcasts to find out what medtech is saying about tax reform.
FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
A panel of experts took a crack at the subject of artificial intelligence to help us sort out how much of a near-term impact the technology could realistically have in healthcare.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.